SCHEMBL867976

SCHEMBL867976

CC(C)N(CC(=O)O)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.41
EYA2 O00167 1/20 0.41
APP P05067 1/20 0.41
ACE P12821 1/20 0.41
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
CHRM2 P08172 1/20 0.39
ADRA2A P08913 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
CYP2C19 P33261 1/20 0.39
ADRA1A P35348 1/20 0.39
DRD3 P35462 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5577032 0.97 TDP1 (0.39) TDP1EYA2APPACEKDM4E
SCHEMBL360546 0.81 MMP2 (0.33) TDP1EYA2APPACECYP1A2
SCHEMBL4962362 0.81 MMP2 (0.33) TDP1EYA2APPACECYP1A2
SCHEMBL186528 0.80 TDP1 (0.39) TDP1EYA2APPACEKDM4E
SCHEMBL9521828 0.79 MEN1 (0.35) TDP1CYP2C19MEN1KMT2A
Ammonia Solution, Strong SCHEMBL3916100 0.78 TDP1 (0.38) TDP1EYA2APPACEKDM4E
SCHEMBL3901854 0.78 TDP1 (0.38) TDP1EYA2APPACEKDM4E
SCHEMBL1322891 0.78 TDP1 (0.38) TDP1EYA2APPACEKDM4E
SCHEMBL676800 0.78 GABRP (0.42) TDP1EYA2APPACEGABRP
SCHEMBL12988839 0.78 TDP1 (0.45) TDP1FFAR3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250281440-A1 METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE NUTRIQUEST, LLC 2025-09-11 US claimed
CN-117820177-A Additive composition for preparing 2-hydroxy-4- (methylthio) butyronitrile and application thereof in preparation of methionine 万华化学集团股份有限公司 2024-04-05 CN claimed
CN-105166407-A Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate TAMINCO 2015-12-23 CN claimed
US-20140316004-A1 TREATMENT OF POULTRY FOR REDUCING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES TAMINCO N.V. (BE) 2014-10-23 US claimed
CN-101426378-B Use of glycine compounds for the preparation of a medicament for the non-therapeutic treatment of poultry for reducing the conversion rate of the feed used for feeding the poultry TAMIN CO 2012-05-23 CN claimed
CN-101827530-A Treatment of pigs for reducing feed conversion ratio or increasing growth rate TAMINCO 2010-09-08 CN claimed
US-20100183580-A1 TREATMENT OF PIGS FOR REDUCING THE FEED CONVERSION RATIO OR INCREASING THE GROWTH RATE TAMINCO NV (BE) 2010-07-22 US claimed
EP-2207432-A1 TREATMENT OF PIGS FOR REDUCING THE FEED CONVERSION RATIO OR INCREASING THE GROWTH RATE Taminco (BE) 2010-07-21 EP claimed
EP-2010005-B1 TREATMENT OF POULTRY FOR REDUCING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES TAMINCO N V (BE) 2009-11-11 EP claimed
CN-101426378-A Treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites TAMIN CO (BE) 2009-05-06 CN claimed
WO-2009033502-A1 TREATMENT OF PIGS FOR REDUCING THE FEED CONVERSION RATIO OR INCREASING THE GROWTH RATE TAMINCO (BE) 2009-03-19 WO claimed
WO-2009034151-A1 TREATMENT OF PIGS FOR REDUCING THE FEED CONVERSION RATIO OR INCREASING THE GROWTH RATE TAMINCO (BE) 2009-03-19 WO claimed
EP-2010005-A1 TREATMENT OF POULTRY FOR INCREASING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES Taminco N.V. (BE) 2009-01-07 EP claimed
US-20080058419-A1 Treatment Of Poultry For Increasing The Feed Conversion Rate Or For Reducing The Incidence Of Ascites TAMINCO NV (BE) 2008-03-06 US claimed
WO-2007107184-A1 TREATMENT OF POULTRY FOR INCREASING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES TAMINCO (BE) 2007-09-27 WO claimed
EP-0319814-B1 METHOD OF PREPARING ASYMMETRICAL DIHYDROPYRIDINES BAYER AG (DE) 1992-09-16 EP claimed
EP-0319814-A2 Method of preparing asymmetrical dihydropyridines BAYER AG (DE) 1989-06-14 EP claimed
US-12622878-B2 Cationic lipid having cystine skeleton NOF CORPORATION (JP) 2026-05-12 US disclosed
EP-0227355-A2 Prodrugs of rapamycin THE UNIVERSITY OF KANSAS (US) 1987-07-01 EP disclosed
US-4650803-A WATER-SOLUBLE ANTITUMOR AGENTS UNIVERSITY OF KANSAS (US) 1987-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100183580-A1 TREATMENT OF PIGS FOR REDUCING THE FEED CONVERSION RATIO OR INCREASING THE GROWTH RATE PIGS, GRHPR, GNMT TDP1 4495/4885EYA2 4881/4885APP 3103/4885
US-20140316004-A1 TREATMENT OF POULTRY FOR REDUCING THE FEED CONVERSION RATE OR FOR REDUCING THE INCIDENCE OF ASCITES OAT, AADAT, HDGF TDP1 4421/4885EYA2 4691/4885APP 2743/4885
US-20250281440-A1 METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE PIGS, GLO1, IGFBP6 TDP1 1156/4885EYA2 4264/4885APP 4554/4885
US-20080058419-A1 Treatment Of Poultry For Increasing The Feed Conversion Rate Or For Reducing The Incidence Of Ascites OAT, AADAT, HDGF TDP1 4414/4885EYA2 4700/4885APP 2776/4885
US-12622878-B2 Cationic lipid having cystine skeleton ABCB7, ABCB4, SLC27A1 TDP1 3987/4885EYA2 4641/4885APP 4042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.